Drug Type Fusion protein |
Synonyms KN 044 |
Target |
Action inhibitors |
Mechanism CTLA4 inhibitors(Cytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Lung Small Cell Carcinoma | Phase 1 | China | 18 Jul 2025 | |
Advanced Lung Small Cell Carcinoma | Phase 1 | China | 18 Jul 2025 | |
Advanced Malignant Solid Neoplasm | Phase 1 | China | 09 Jan 2020 | |
Locally Advanced Malignant Solid Neoplasm | Phase 1 | China | 09 Jan 2020 |